Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIII.aj

Bronchial stump dehiscence

Publications

Groetzner J, Kur F, Spelsberg F, Behr J, Frey L, Bittmann I, Vogeser M, Ueberfuhr P, Meiser B, Hatz R, Reichart B,

Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2004 May;23;632-8 — 2004 May — 632-8

King-Biggs MB, Dunitz JM, Park SJ, Kay Savik S, Hertz MI

Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation.

Transplantation 2003 May 15;75;1437-43 — 2003 May 15 — 1437-43